Merit Medical Systems, Inc. (NASDAQ:MMSI) Shares Sold by SG Americas Securities LLC

SG Americas Securities LLC cut its holdings in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 84.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,132 shares of the medical instruments supplier’s stock after selling 11,314 shares during the period. SG Americas Securities LLC’s holdings in Merit Medical Systems were worth $162,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Public Employees Retirement System of Ohio grew its holdings in shares of Merit Medical Systems by 69.3% during the third quarter. Public Employees Retirement System of Ohio now owns 103,099 shares of the medical instruments supplier’s stock valued at $7,116,000 after buying an additional 42,191 shares during the last quarter. FMR LLC grew its holdings in shares of Merit Medical Systems by 26.0% during the third quarter. FMR LLC now owns 607,881 shares of the medical instruments supplier’s stock valued at $41,956,000 after buying an additional 125,605 shares during the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of Merit Medical Systems by 161.7% during the third quarter. Envestnet Asset Management Inc. now owns 141,938 shares of the medical instruments supplier’s stock valued at $9,797,000 after buying an additional 87,711 shares during the last quarter. Trillium Asset Management LLC grew its holdings in shares of Merit Medical Systems by 18.0% during the third quarter. Trillium Asset Management LLC now owns 97,874 shares of the medical instruments supplier’s stock valued at $6,755,000 after buying an additional 14,951 shares during the last quarter. Finally, Mariner LLC grew its holdings in shares of Merit Medical Systems by 352.9% during the third quarter. Mariner LLC now owns 31,813 shares of the medical instruments supplier’s stock valued at $2,196,000 after buying an additional 24,788 shares during the last quarter. 99.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on MMSI. Needham & Company LLC reaffirmed a “buy” rating and issued a $88.00 price target on shares of Merit Medical Systems in a report on Thursday, April 11th. Oppenheimer upped their price target on shares of Merit Medical Systems from $82.00 to $87.00 and gave the company an “outperform” rating in a report on Thursday, February 29th. Piper Sandler upped their price target on shares of Merit Medical Systems from $88.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, January 12th. Barrington Research upped their price target on shares of Merit Medical Systems from $96.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 29th. Finally, StockNews.com lowered shares of Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Friday. Two research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $92.50.

Merit Medical Systems Trading Down 0.9 %

Shares of Merit Medical Systems stock opened at $71.96 on Tuesday. The firm has a 50-day simple moving average of $75.65 and a two-hundred day simple moving average of $73.47. The company has a market cap of $4.18 billion, a P/E ratio of 44.42, a price-to-earnings-growth ratio of 2.02 and a beta of 0.89. Merit Medical Systems, Inc. has a fifty-two week low of $62.58 and a fifty-two week high of $85.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 3.95 and a current ratio of 5.45.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Wednesday, February 28th. The medical instruments supplier reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.77 by $0.04. The business had revenue of $324.52 million during the quarter, compared to the consensus estimate of $320.66 million. Merit Medical Systems had a net margin of 7.51% and a return on equity of 14.63%. The company’s revenue was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.79 earnings per share. As a group, equities analysts predict that Merit Medical Systems, Inc. will post 3.31 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, CFO Raul Jr. Parra sold 6,480 shares of the company’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $73.95, for a total transaction of $479,196.00. Following the completion of the transaction, the chief financial officer now owns 12,007 shares in the company, valued at approximately $887,917.65. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, CFO Raul Jr. Parra sold 6,480 shares of the company’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $73.95, for a total transaction of $479,196.00. Following the completion of the transaction, the chief financial officer now owns 12,007 shares in the company, valued at approximately $887,917.65. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Thomas James Gunderson sold 18,157 shares of the company’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $76.03, for a total transaction of $1,380,476.71. Following the transaction, the director now owns 19,257 shares of the company’s stock, valued at approximately $1,464,109.71. The disclosure for this sale can be found here. Insiders sold a total of 69,637 shares of company stock worth $5,351,673 in the last 90 days. Insiders own 3.70% of the company’s stock.

Merit Medical Systems Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.